Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 203510
Company: PARAGON BIOTECK
Company: PARAGON BIOTECK
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
PHENYLEPHRINE HYDROCHLORIDE | PHENYLEPHRINE HYDROCHLORIDE | 2.5% | SOLUTION/DROPS;OPHTHALMIC | Prescription | AT | Yes | Yes |
PHENYLEPHRINE HYDROCHLORIDE | PHENYLEPHRINE HYDROCHLORIDE | 10% | SOLUTION/DROPS;OPHTHALMIC | Prescription | AT | Yes | Yes |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
03/21/2013 | ORIG-1 | Approval | Type 7 - Drug Already Marketed without Approved NDA | PRIORITY |
Label (PDF)
Letter (PDF) Review Summary Review (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/203510s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/203510Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/203510_phenylephrine_toc.cfm https://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/203510Orig1s000SumR.pdf |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
12/08/2022 | SUPPL-5 |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203510s005lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/203510Orig1s005ltr.pdf | ||
04/17/2020 | SUPPL-2 | Labeling-Package Insert, Labeling-Container/Carton Labels |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203510s002lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/203510Orig1s002ltr.pdf | |
10/08/2013 | SUPPL-1 | Manufacturing (CMC) |
Label is not available on this site. |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
12/08/2022 | SUPPL-5 | Manufacturing (CMC) | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203510s005lbl.pdf | |
04/17/2020 | SUPPL-2 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203510s002lbl.pdf | |
04/17/2020 | SUPPL-2 | Labeling-Container/Carton Labels | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203510s002lbl.pdf | |
03/21/2013 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/203510s000lbl.pdf |
PHENYLEPHRINE HYDROCHLORIDE
SOLUTION/DROPS;OPHTHALMIC; 2.5%
TE Code = AT
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
PHENYLEPHRINE HYDROCHLORIDE | PHENYLEPHRINE HYDROCHLORIDE | 2.5% | SOLUTION/DROPS;OPHTHALMIC | Prescription | Yes | AT | 207926 | ALCON |
PHENYLEPHRINE HYDROCHLORIDE | PHENYLEPHRINE HYDROCHLORIDE | 2.5% | SOLUTION/DROPS;OPHTHALMIC | Prescription | No | AT | 216859 | MANKIND PHARMA |
PHENYLEPHRINE HYDROCHLORIDE | PHENYLEPHRINE HYDROCHLORIDE | 2.5% | SOLUTION/DROPS;OPHTHALMIC | Prescription | Yes | AT | 203510 | PARAGON BIOTECK |
SOLUTION/DROPS;OPHTHALMIC; 10%
TE Code = AT
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
PHENYLEPHRINE HYDROCHLORIDE | PHENYLEPHRINE HYDROCHLORIDE | 10% | SOLUTION/DROPS;OPHTHALMIC | Prescription | Yes | AT | 207926 | ALCON |
PHENYLEPHRINE HYDROCHLORIDE | PHENYLEPHRINE HYDROCHLORIDE | 10% | SOLUTION/DROPS;OPHTHALMIC | Prescription | No | AT | 216496 | MANKIND PHARMA |
PHENYLEPHRINE HYDROCHLORIDE | PHENYLEPHRINE HYDROCHLORIDE | 10% | SOLUTION/DROPS;OPHTHALMIC | Prescription | Yes | AT | 203510 | PARAGON BIOTECK |